Natasha Rozenkrants

577 total citations
10 papers, 273 citations indexed

About

Natasha Rozenkrants is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Natasha Rozenkrants has authored 10 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Natasha Rozenkrants's work include Nitric Oxide and Endothelin Effects (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Pain Mechanisms and Treatments (3 papers). Natasha Rozenkrants is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Pain Mechanisms and Treatments (3 papers). Natasha Rozenkrants collaborates with scholars based in United States, Spain and France. Natasha Rozenkrants's co-authors include Marciano Sablad, Tadimeti S. Rao, Kent T. Symons, Joseph E. Payne, Stewart A. Noble, Andrew K. Shiau, Christian A. Hassig, Peter J. Rix, Céline Bonnefous and Nicholas D. Smith and has published in prestigious journals such as The EMBO Journal, Scientific Reports and The FASEB Journal.

In The Last Decade

Natasha Rozenkrants

10 papers receiving 261 citations

Peers

Countries citing papers authored by Natasha Rozenkrants

Since Specialization

Citations

This map shows the geographic impact of Natasha Rozenkrants's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Rozenkrants with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Rozenkrants more than expected).

Fields of papers citing papers by Natasha Rozenkrants

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Rozenkrants. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Rozenkrants. The network helps show where Natasha Rozenkrants may publish in the future.

Co-authorship network of co-authors of Natasha Rozenkrants

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Rozenkrants. A scholar is included among the top collaborators of Natasha Rozenkrants based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Rozenkrants. Natasha Rozenkrants is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis 2016 ·Scientific Reports ·Xiaohua Xue, Pejman Soroosh, (unknown), (unknown), Marciano Sablad, Natasha Rozenkrants, Jingxue Yu, Glenda Castro, Homayon Banie, Wai‐Ping Fung‐Leung, Luis F. Santamaria‐Babí, (unknown), M. Albers, Kristi Leonard, Alison Budelsky, Anne M. Fourie	53
2	Kinase activity of phosphoinositide 3‐kinase gamma (PI3Kγ) is important for neutrophil infiltration in inflammation 2012 ·The FASEB Journal ·Marciano Sablad, Glenda Castro, Natasha Rozenkrants, Karen Ngo, Tadimeti S. Rao, Yan Zhang, Wai‐Ping Fung‐Leung	1
3	Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Sergio G. Durón, Andrew B. Lindstrom, Céline Bonnefous, Hui Zhang, Xiaohong Chen, Kent T. Symons, Marciano Sablad, Natasha Rozenkrants, Yan Zhang, Li Wang, (unknown), Andrew K. Shiau, Stewart A. Noble, Peter J. Rix, Tadimeti S. Rao, Christian A. Hassig, Nicholas D. Smith	7
4	Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases 2010 ·Journal of Pharmacology and Experimental Therapeutics ·Kent T. Symons, (unknown), Mark E. Massari, John V. Anzola, Lena Staszewski, Li Wang, (unknown), Steven Dorow, Jerry Muhammad, Marciano Sablad, Natasha Rozenkrants, (unknown), Joseph E. Payne, Peter J. Rix, Andrew K. Shiau, Stewart A. Noble, Nicholas D. Smith, Christian A. Hassig, Yan Zhang, Tadimeti S. Rao	12
5	Discovery of Dual Inducible/Neuronal Nitric Oxide Synthase (iNOS/nNOS) Inhibitor Development Candidate 4-((2-Cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) Part 2: Identification of a Novel, Potent, and Selective Series of Benzimidazole-Quinolinone iNOS/nNOS Dimerization Inhibitors That Are Orally Active in Pain Models 2010 ·Journal of Medicinal Chemistry ·Joseph E. Payne, Céline Bonnefous, Kent T. Symons, (unknown), Marciano Sablad, Natasha Rozenkrants, Yan Zhang, Li Wang, (unknown), Andrew K. Shiau, Stewart A. Noble, Peter J. Rix, Tadimeti S. Rao, Christian A. Hassig, Nicholas D. Smith	52
6	KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization 2009 ·Molecular Pharmacology ·Kent T. Symons, Mark E. Massari, (unknown), (unknown), Jeffrey Roppe, Céline Bonnefous, Joseph E. Payne, Nicholas D. Smith, Stewart A. Noble, Marciano Sablad, Natasha Rozenkrants, Yan Zhang, Tadimeti S. Rao, Andrew K. Shiau, Christian A. Hassig	11
7	Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models 2009 ·Journal of Medicinal Chemistry ·Céline Bonnefous, Joseph E. Payne, Jeffrey Roppe, Hui Zhuang, Xiaohong Chen, Kent T. Symons, (unknown), Marciano Sablad, Natasha Rozenkrants, Yan Zhang, Li Wang, Daniel L. Severance, John P. Walsh, (unknown), Andrew K. Shiau, Stewart A. Noble, Peter J. Rix, Tadimeti S. Rao, Christian A. Hassig, Nicholas D. Smith	57
8	Inhibition of Inducible Nitric Oxide Synthase Expression by a Novel Small Molecule Activator of the Unfolded Protein Response 2008 ·PubMed ·Kent T. Symons, Mark E. Massari, (unknown), (unknown), David Jenkins, Mark R. Herbert, Timothy C. Gahman, Stewart A. Noble, Natasha Rozenkrants, Yan Zhang, Tadimeti S. Rao, Andrew K. Shiau, Christian A. Hassig	4
9	Synthesis and structure–activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7 2005 ·Bioorganic & Medicinal Chemistry Letters ·Yi Hu, Lifu Ma, (unknown), Melissa S. Wong, Bei Li, (unknown), (unknown), Tyzoon Nomanbhoy, (unknown), (unknown), Jonathan S. Rosenblum, Natasha Rozenkrants, (unknown), William C. Ripka, Anna Katrin Szardenings, John W. Kozarich, Kevin Shreder	26
10	A new α‐helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III 2004 ·The EMBO Journal ·Nicolas Leulliot, Sophie Quevillon‐Chéruel, Marc Graille, Herman van Tilbeurgh, Thomas C. Leeper, Katherine S. Godin, Thomas E. Edwards, Snorri Th. Sigurdsson, Natasha Rozenkrants, Roland Nagel, Manuel Ares, Gabriele Varani	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact